CureMatch
×
  • Physicians
  • Patients
  • Employers
  • About Us
  • News
    • CureMatch News
    • Validation and Research
    • Events & Conferences
  • Contact
  • Login
Jessica Federer

Jessica Federer

FORMER CHIEF DIGITAL OFFICER, BAYER

Recognized as one of the top 100 global CDOs, a “Power-Lady” of the German economy, and a leading Health Tech Influencer, Jessica Federer is adept at translating digital developments into meaningful advancements for business and society. Federer is a Co-Founder of Lyearn and Founder of Innovayte. She serves as an advisor for private technology companies, and is on the m-Powering Development Advisory Board for the UN Agency for Information and Communications Technology (ITU). Previously, Federer was the Chief Digital Officer and worldwide head of Digital Development at Bayer, a global life sciences leader in the areas of human, animal, and plant health. While at Bayer, she held positions in Global Regulatory Affairs, Market Access, Communications and Public Affairs. She started her public health career as an analyst at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services. Federer earned a Bachelor of Science from the George Washington University, and a Master of Public Health from Yale. She and her husband live in New York City.

logo

+1 (858) 284-0488

FAX: +1 (858) 430-5813

Quick Links

  • Physicians
  • About CureMatch
  • News and Latest Posts
    • CureMatch News
    • Validation and Case Studies
    • Events and Conferences
  • Contact Us
  • FAQ

Latest News and Results

  • Interview with Dr. Razelle Kurzrock of CureMatch: Why Patients Need Precision Cancer Medicine Apr 6

    In this dynamic interview, Chief Medical Advisor, Dr. Kurzrock, sits down with Michelle Morand, Co-Founder...

  • New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs Mar 28

    The Research Consortium announced the release of a new study today that challenges common misconceptions...

  • CureMatch Names Life Sciences Executive David Szekeres as Board Director Feb 22

    CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine...

© 2021 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice

We’d like to send you a CureMatch Sample Analysis

 

Sample Analysis Download Form

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy

Some pages of this website are intended for healthcare professionals

This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.

Otherwise, you will be redirected to the institutional part of this website.

Thank you for your understanding.

I am a healthcare professionalI am not a healthcare professional

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data